Literature DB >> 6309113

The pituitary gland in untreated Addison's disease. A histologic and immunocytologic study of 18 adenohypophyses.

B W Scheithauer, K Kovacs, R V Randall.   

Abstract

The pituitary glands of 18 patients with untreated Addison's disease were studied by histologic and immunocytochemical methods. Adrenal destruction was caused by tuberculosis (13 cases) or autoimmune adrenalitis (five cases), and the duration of the adrenal insufficiency ranged from one to 16 years. Both diffuse and nodular hyperplasia of corticotropic cells were evident in each case, and the extent of hyperplasia correlated with the duration of disease. In five cases, nodular proliferations with morphologic features between those of hyperplasia and those of adenoma, termed tumorlets, were identified, as were two microadenomas, only one of which was available for study. In all instances, the proliferating corticotrophs stained positively with PAS and were immunoreactive for adrenocorticotropic hormone and beta-endorphin. We conclude that diffuse and nodular corticotroph hyperplasia are common in untreated Addison's disease, although frank adenoma formation seems to be rare. The latter may be related to the short duration of disease or may imply the absence of additional, unknown factors that are required for adenoma growth.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6309113

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  14 in total

Review 1.  Aspects of anterior pituitary growth, with special reference to corticotrophs.

Authors:  A M McNicol; E Carbajo-Perez
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

2.  Bilateral adrenocortical adenomas causing ACTH-independent Cushing's syndrome at different periods: a case report and discussion of corticosteroid replacement therapy following bilateral adrenalectomy.

Authors:  S C Tung; P W Wang; T L Huang; W C Lee; W J Chen
Journal:  J Endocrinol Invest       Date:  2004-04       Impact factor: 4.256

3.  The diurnal rhythm of adrenocorticotropic hormone secretion in the assessment of the adequacy of replacement therapy in primary chronic adrenal failure.

Authors:  V V Fadeev; E P Gitel; G A Mel'nichenko
Journal:  Neurosci Behav Physiol       Date:  2001 May-Jun

4.  [The 2017 WHO classification of pituitary tumors].

Authors:  Wolfgang Saeger
Journal:  Pathologe       Date:  2021-04-20       Impact factor: 1.011

5.  The pituitary in Turner syndrome.

Authors:  B W Scheithauer; K Kovacs; E Horvath; W F Young; R V Lloyd
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

Review 6.  Medical management of pituitary adenomas: structural and ultrastructural changes.

Authors:  Sylvia L Asa; Shereen Ezzat
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

7.  The pituitary in klinefelter syndrome.

Authors:  B W Scheithauer; M Moschopulos; K Kovacs; B S Jhaveri; T Percek; R V Lloyd
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

8.  Prolactin-producing pituitary adenoma associated with prolactin cell hyperplasia.

Authors:  Sergio Vidal; Eva Horvath; Luis V Syro; Humberto Uribe; Sandy Cohen; Kalman Kovacs
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

Review 9.  Combined sellar gangliocytoma and pituitary adenoma in acromegaly or Cushing's disease. A report of 3 cases.

Authors:  W Saeger; M J Puchner; D K Lüdecke
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

10.  Pituitary Corticotroph Adenoma in a Woman with Long-Standing Addison's Disease: A Histologic, immunocytochemical, Electron Microscopic, and In Situ Hybridization Study.

Authors:  Kalman Kovacs; Lucia Stefaneanu; Eva Horvath; Michael Buchfelder; Rudolph Fahlbusch; Peter H. Althoff; Christine Moore
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.